The Scientist

» history and genetics & genomics

Most Recent

image: Another Role for ApoE?

Another Role for ApoE?

By | January 20, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

3 Comments

image: Mutant Mosquitoes Deployed to Stop Zika, Dengue

Mutant Mosquitoes Deployed to Stop Zika, Dengue

By | January 19, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

0 Comments

image: GM Paper Flagged by Politician Retracted

GM Paper Flagged by Politician Retracted

By | January 18, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

0 Comments

image: Thermo Fisher to Acquire Affymetrix

Thermo Fisher to Acquire Affymetrix

By | January 11, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

0 Comments

image: Disease-Linked Genes Questioned

Disease-Linked Genes Questioned

By | January 6, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

0 Comments

image: TS Picks: CRISPR Patent Edition

TS Picks: CRISPR Patent Edition

By | January 5, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

3 Comments

image: CRISPR Improves Disease in Adult Mice

CRISPR Improves Disease in Adult Mice

By | January 4, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

1 Comment

image: A Century of Science on Stamps

A Century of Science on Stamps

By | January 1, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

0 Comments

image: All Together Now

All Together Now

By | January 1, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

1 Comment

image: Contributors

Contributors

By | January 1, 2016

Key Alzheimer’s disease–related protein may be a transcriptional regulator.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech